Background. Hospitalizations due to pneumonia increase steadily with age. The purpose of this study is to explore differences in host-and pathogen-related factors, process of care, and outcome as a function of age in elderly patients with bacteremic pneumococcal pneumonia and identify factors related to mortality.
P
NEUMONIA caused by Streptococcus pneumoniae is one of the leading causes of hospital admission and mortality in patients older than 65 years (1) . Approximately 20% of patients diagnosed with pneumococcal pneumonia develop bloodstream infections, this being traditionally associated with poorer and slower recovery (2, 3) . Recently, some authors have not found this association, although their studies have focused on the general population and not only on elderly patients (4) .
The progressive population aging, the increase in the incidence of pneumococcal pneumonia with age (5) , and improvement in survival rates in the last decade in elderly patients (6) make it important to explore the characteristics of the disease in various subgroups of the elderly population to improve the planning of care.
To date, little information is available regarding the process of care or host-and pathogen-related factors associated with bacteremic pneumococcal pneumonia (BPP) in elderly and very elderly patients (≥80 years old). For this reason, we assessed the impact of age group (65-79 vs ≥80 years old) on clinical presentation, process of care markers, outcome, and risk factors associated with 30-day mortality in a large cohort of elderly patients.
Materials and Methods

Setting, Patients, and Study Design
The study was conducted between January 2002 and January 2010 in two hospitals (Cruces University Hospital and Galdakao-Usansolo Hospital) in the Basque Country (Spain). We prospectively included all adults admitted for BPP. Patients were divided into two age groups: younger than 65 and aged 65 and older. For the purpose of the analysis, patients aged 65 and older were classified as: (i) elderly patients, aged between 65 and 79 years and (ii) very elderly patients, aged 80 and older. We excluded patients with neutropenia or HIV infection and other immunosuppressed patients including transplant recipients.
A local ethics committee approved the study.
Clinical Assessment and Follow-up
During the initial visit, a thorough medical history, physical examination, and appropriate blood tests were performed. Patients were empirically treated in accordance with current Spanish guidelines. The severity of patients' clinical condition was assessed on admission using the Pneumonia Severity Index (PSI) (7) . The following data were collected: (i) demographic data, (ii) epidemiological data, (iii) influenza and pneumococcal vaccination status, (iv) comorbidities, (v) clinical and examination data, (vi) blood test results and radiological findings on admission, (vii) clinical course, and (viii) antibiotic treatment administered.
Two consecutive blood cultures were taken for all patients within 24 hours after admission. Tests were conducted to assess the susceptibility of S pneumoniae to different antibiotics. Serotypes were assessed and grouped according to their associated mortality (8) (high mortality: serotypes 3, 6A, 6B, 9N, 19F, 19A, and 23F and lower mortality: serotypes 1, 7F, 8, 4, and 5).
To assess the treatment, the following variables were studied: (i) whether antibiotics were appropriate in accordance with the recommendations of the Spanish Society of Pulmonology (SEPAR) (9), (ii) and (iii) whether antibiotic treatments were started within 4 or 8 hours after arrival at the emergency unit, respectively, and (iv) the type of antibiotics administered.
Regarding inhospital course and outcome, the following variables were studied: (i) admission to the intensive care unit, (ii) use of invasive mechanical ventilation, (iii) septic shock, (iv) treatment failure, (v) early and late inhospital mortality, (vi) 30-day mortality, and (vii) length of hospital stay.
Definitions
Pneumonia was defined as the presence of new pulmonary infiltrate on the chest x-ray together with signs and symptoms suggestive of lower respiratory tract infection.
Septic shock was defined as a systolic blood pressure less than 90 mmHg and a need for vasopressor drugs for at least 4 hours, after fluid therapy (10) . Treatment was considered to have failed when patients' clinical condition worsened during their hospital stay with: hemodynamic instability; appearance or worsening of respiratory failure; a need for mechanical ventilation; progression of the pneumonia, as indicted by radiological evidence or the appearance of new foci of infection; and persistence or reappearance of fever, if a change of treatment was required (11) . Deaths within less than or equal to 72 hours after hospital admission were used to calculate early mortality. The diagnosis of altered mental status was based on observation that the mental state of the patient was not normal and that this was a new phenomenon, except if an individual was known to have had dementia prior to admission, when deterioration with respect to baseline was required (7) .
Statistical Analysis
Descriptive analysis was undertaken, using frequencies and percentages, means and SDs, or medians and interquartile ranges. Characteristics of all the patients included were compared with two different groupings ( Univariate logistic regression models were used to identify factors associated with 30-day mortality among patients aged 65 years and older. A multivariate logistic regression model was then constructed to assess the statistical significance of each independent factor. The dependent variable was 30-day mortality, and independent variables were factors found to have p value less than .15 in the univariate analysis. The interactions between independent variables were also considered. In the final multivariate model, only variables with p value less than .05 were included. Results were expressed as odds ratios (ORs) and 95% confidence intervals (CIs). The predictive ability of the final multivariate model was assessed by area under the receiver operating characteristic curve analysis, and the model calibration by comparing the observed with the predicted 30-day mortality using the Hosmer-Lemeshow goodness-of-fit test.
A p value less than .05 was considered statistically significant. Data analysis was performed using the SAS software for Windows version 9.2 (SAS Institute, Cary, NC).
Results
During the study period, 399 patients with BPP were identified, of whom 225 (56.39%) were aged 65 and older. Table 1 shows the baseline characteristics of all patients and differences as a function of their age (<65 vs ≥65 years and 65-79 vs ≥80 years).
Focusing on patients aged 65 and older, comorbidities such as chronic obstructive pulmonary disease and liver disease were more common in elderly patients. No statistically significant differences were observed in other clinical characteristics, blood test results or radiological findings. The very elderly patients were more frequently classified in the higher risk classes of the PSI (IV-V) (p < .0001). No significant differences were found in the rates of resistance to antibiotics tested. In 184 (81.77%) patients, the pneumococcal serotypes were identified, the most frequent serotypes being 3 (27.19%), 14 (9.23%), and 8 (8.70%), but differences in risk of death by serotype group were not significant. The antibiotic treatments used are reported in Table 2 . Very elderly patients received antibiotics earlier, but the duration of the treatment was shorter than that in the elderly group (12.49 vs 15.02 days, p = .010). Table 3 shows the inhospital course and outcome indicators. Very elderly patients were less likely than elderly patients to be admitted to the intensive care unit or require mechanical ventilation, but there were no statistically significant differences in rates of septic shock or treatment failure during the hospital stay. Overall, 37 out of 399 (9.27%) patients died within 30 days, of whom 26 out of 225 (11.55%) were aged 65 and older. Very elderly patients had a higher rate of both inhospital (16.47% vs 7.14%, p = .028) and 30-day (20% vs 6.43%, p = .002) mortality, but a significantly shorter mean hospital stay than the elderly patients (6.89 ± 5.37 vs 10.54 ± 12.02, p = .014). Table 4 summarizes the results of the univariate analysis of factors potentially associated with 30-day all-cause mortality in patients aged 65 and older. In the multivariate analysis, the independent factors that were significantly associated with 30-day mortality (Table 5) curve for this model for predicting mortality was 0.9332. The model was a good fit to the data (Hosmer-Lemeshow, p = .933).
Discussion
This study provides a comprehensive evaluation of hostrelated factors, process of care, and mortality risk factors in a consecutive series of patients (age: ≥65 years) diagnosed with BPP. We found that age, altered mental status on admission, respiratory rate more than or equal to 30 breaths/ min, low systolic blood pressure, blood urea nitrogen more than 30 mg/dL, and bilateral multilobar involvement are independent predictors of mortality. The very elderly patients had poorer outcomes-inhospital and 30-day mortality-despite a lack of differences between groups in the presentation of the disease.
The differences observed in clinical presentation and outcome as a function of age confirm that pneumonia in patients aged 65 years and older is a different entity. In this context, our sample is particularly interesting for three reasons: (i) the type of population studied, elderly and very elderly patients; (ii) the characteristics of the disease itself, all the cases being patients with bacteremic pneumonia; and (iii) the design of the study, both the sample size and that the data were prospectively collected on consecutive patients. To our knowledge, this is among the largest series reported focusing on this topic.
Overall, 16% of patients in this series, mostly from the elderly group, were to the intensive care unit. This indicates the negative impact of advanced age and the type of disease on indication for to the intensive care unit (12, 13) .
In this study, the mortality rate of patients aged 65 years and older was relatively low (11.55%) compared with that reported in other studies (10%-30%) (14) . The early use of empirical antibiotic treatment in more than 90% of cases (15, 16) may have a positive influence on these outcomes. This treatment was appropriate according to the SEPAR guidelines (9) in less than 70% of cases, however, mainly due to the use of beta-lactams alone. Although some authors consider such treatment to be suboptimal, there is ongoing debate as to whether the addition of macrolides is beneficial in this type of pneumonia (17). Notes: AUC = area under the receiver operating characteristic curve; CI = confidence interval; OR = odds ratio. *A significant value for the Hosmer-Lemeshow statistic indicates a significant deviation between predicted and observed outcomes.
In this study, the combination of the six factors identified robustly predicts mortality as reflected in an area under the receiver operating characteristic curve of over 0.90. Previous studies have produced various different rules for predicting mortality in elderly patients diagnosed with pneumonia (18) (19) (20) (21) , but few studies have focused on the subgroup with pneumococcal bacteremia.
The role of age as a prognostic factor for pneumonia is controversial. Despite being the most important risk factor related to mortality in the PSI, its usefulness has been questioned, for overestimating the risk in some patients (22, 23) . Indeed, other authors have not found that age has a negative effect on survival (20, 22, 24, 25) . These findings may be explained by age having less weight as a prognostic factor than other host-dependent factors in series that only include elderly patients. In contrast, in our study, after adjusting for other factors and excluding any interactions between independent variables, we observed a positive correlation between age and inhospital and 30-day mortality. These differences may be mainly attributable to the characteristics of the patients included (invasive pneumococcal disease in all cases), the lower number of comorbid conditions, and pneumococcal vaccination. On the other hand, our findings are consistent with those from previous studies in patients with community-acquired pneumococcal bacteremia (26) (27) (28) and justify the routine use of the pneumococcal vaccination in this age group.
Altered mental status, respiratory rate more than or equal to 30 breaths/min, low systolic blood pressure, blood urea nitrogen more than 30 mg/dL, and bilateral or multilobar involvement on chest x-ray are classical predictive factors of mortality included in various prognostic scales validated both for the general (7, 29) and elderly populations (24) . Our results show that mortality is mainly associated with the severity of the infectious condition itself. The lack of statistically significant differences in the process of care between patients who died and those who survived and the early mortality rate of more than 60% may explain these results. In contrast, the presence of comorbidities was not related to a poorer prognosis, despite previous reports of an association with both the number (28) and severity of comorbidities in the short (30) and long term (15) .
Our study has some limitations:
1. The most important limitation was the lack of functional assessment. Functional status, in addition to PSI, could provide information about mortality without overestimating the risk related to chronological age (21, 22) . 2. The analysis of the mortality risk factors was performed for all patients aged 65 years and older and not separately in the subgroups by age, given that the small number of patients who died would weaken the statistical power of the tests used.
3. In the multivariate analysis, we did not adjust for the use of antibiotic therapy including macrolides, given that this was prescribed in only 13 patients. 4 . Only a small number of institutionalized patients were included; therefore, it is not possible to draw conclusions for this subgroup of the population.
To summarize, this study demonstrates that in a large population of patients (age: ≥65 years) diagnosed with BPP, the very elderly group have poorer outcomes despite a lack of statistically significant differences in host-related factors or the process of care compared with the younger elderly group. We also found that mortality is mainly associated with age and the severity of the infectious condition itself. Adequate early empirical antibiotic treatment has a very important role in the design of strategies for improving the process of care in these patients.
